Pennsylvania Attorney General Sues Insulin Makers and Pharmacy Benefit Managers

Harrisburg Lancaster Lebanon York, PA, October 15, 2026 —

Pennsylvania Attorney General Dave Sunday has filed a lawsuit in Commonwealth Court accusing major insulin manufacturers and pharmacy benefit managers (PBMs) of participating in a pricing scheme that allegedly drove insulin costs up by more than 1,000%.

The suit alleges that the companies’ conduct potentially harmed millions of Pennsylvanians. The summary of the lawsuit does not identify the manufacturers or PBMs named as defendants, explain how the alleged pricing scheme operated, or provide details about the specific insulin products or prices involved.

The allegation concerns insulin costs in Pennsylvania, but the information provided does not specify when the alleged conduct occurred or how the claimed increase of more than 1,000% was calculated. It also does not describe the legal claims made in the filing, the relief sought by the attorney general, or a timeline for the case.

The allegations have not been established as findings by a court. No responses from the accused manufacturers or PBMs were included in the available information. The names of the companies and any statements from them were not provided.

The case was filed in Commonwealth Court, according to the summary. Further details about the filing, including its date and the next steps in the proceeding, were not provided. The information available does not indicate whether the court has taken any action on the lawsuit.

Story summarized from the original created by Whitney Downard on penncapital-star.com, see more information here.

Media gallery